WHAT: A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of "good" ...

Please provide your email address to receive an email when new articles are posted on . Adults taking oral fenofibrate had a 27% reduction in diabetic eye disease progression over 4 years. Fenofibrate ...

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial ...

Use of the cholesterol-lowering drug fenofibrate had a modest but statistically significant association with reduced risk of vision-threatening diabetic retinopathy (VTDR), according to results of a ...

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial.

The study was a randomized, placebo-controlled comparison of the effects of daily treatment with fenofibrate 160 mg, ezetimibe-simvastatin 10/20 mg, ezetimibe-simvastatin 10/20 mg plus fenofibrate 160 ...

Fenofibrate was associated with a reduced risk of progression to vision-threatening forms of diabetic retinopathy in a new large database study. The oral drug typically prescribed to lower lipids is ...

The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative 27% over 4 years compared with placebo (22.7% vs 29.2%, P=0.006), reported David Preiss, MBChB, PhD, of the ...

Q: The doctor added fenofibrate to my meds because I had high triglycerides (400-plus). Within six weeks, my triglycerides were down to 179. As an extra benefit, the uncontrolled diarrhea I’ve been ...